Work

Multimodal biomarkers in chikungunya arthritis: clinical phenotyping and a research agenda for personalized therapy

Year: 2026
Type: article
Abstract: Background Chikungunya arthritis comprises overlapping pain-dominant, periarticular, inflammatory, and rheumatoid arthritis (RA)-like clinical phenotypes. Symptom duration alone does not capture this heterogeneity. Scope This narrative review evaluates virological assays, antiviral and autoimmune serology, inflammatory mediators, imaging, and clinical outcomes. Human observations are distinguished from animal and cell-based mechanisms. Findings Most biomarker evidence is exploratory. Associations with concurrent symptoms must be distinguished from prediction of later disease and from prediction of differential treatment benefit. Small samples, heterogeneous assays and sampling times, treatment exposure, and limited external validation restrict interpretation. Neither persistent antiviral antibodies nor an isolated cytokine elevation identifies a validated treatment-responsive subgroup. Tissue viral RNA or antigen does not establish productive infection or a causal explanation for persistent symptoms. Clinical phenotypes are observable states; proposed mechanistic endotypes remain unvalidated. Implications Current assessment should integrate disease phase, objective inflammation, functional burden, comorbidity, and alternative diagnoses. Evidence for methotrexate is limited by combination regimens, uncontrolled observations, and small comparative trials. Antivirals, neutralizing antibodies, and pathway-targeted immunomodulators remain investigational for CHIKV arthritis. Personalized treatment is a research agenda requiring longitudinal cohorts and prospective biomarker-by-treatment interaction trials, rather than a currently available biomarker-directed strategy.
Authors: Ruifeng Lin(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing), Wenxia Lin(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing), Jiabao Xu(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing), Yangtao Liu(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing), Hongjie Zhang(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft, Writing – review & editing), Xiaoling Chen(Data curation, Investigation, Writing – review & editing), Hanbin Liu(Data curation, Investigation, Writing – review & editing), Siqi Zhang(Data curation, Investigation, Writing – review & editing), Qingqing Zhang(Data curation, Investigation, Writing – review & editing), Jiani Liu(Data curation, Investigation, Writing – review & editing), Sheng Yu(Data curation, Investigation, Visualization, Writing – review & editing), Qingyun Li(Data curation, Investigation, Writing – review & editing), Xiaodong Wang(Data curation, Investigation, Writing – review & editing), Shixian Chen(Data curation, Investigation, Writing – review & editing), Junqing Zhu(Conceptualization, Project administration, Supervision, Writing – review & editing), Juan Li(Conceptualization, Project administration, Supervision, Writing – review & editing), Meng Li(Conceptualization, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233753510
FWCI:
Cites: 99
Cited by:
Related to: 10